share_log

This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Benzinga ·  Dec 23, 2024 23:44

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Jefferies analyst David Stanton downgraded the rating for Mesoblast Limited (NASDAQ:MESO) from Buy to Hold. Mesoblast shares closed at $14.63 on Friday. See how other analysts view this stock.
  • William Blair analyst Sami Corwin downgraded Applied Therapeutics, Inc. (NASDAQ:APLT) from Outperform to Market Perform. Applied Therapeutics shares closed at $0.8801 on Friday. See how other analysts view this stock.
  • BTIG analyst Thomas Catherwood downgraded the rating for Innovative Industrial Properties, Inc. (NYSE:IIPR) from Buy to Neutral. NCR Atleos shares closed at $73.66 on Friday. See how other analysts view this stock.

Considering buying MESO stock? Here's what analysts think:

big

Read This Next:

  • Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment